Wave Life Sciences Ltd.
WVE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,228 | $1,066 | $1,313 | $1,998 |
| - Cash | $196 | $208 | $243 | $302 |
| + Debt | $20 | $22 | $24 | $25 |
| Enterprise Value | $1,051 | $879 | $1,094 | $1,721 |
| Revenue | $8 | $9 | $9 | $84 |
| % Growth | -12.5% | -5.2% | -89% | – |
| Gross Profit | $8 | $7 | $7 | $84 |
| % Margin | 100% | 74.8% | 76.4% | 100% |
| EBITDA | -$52 | -$51 | -$48 | $25 |
| % Margin | -678.5% | -581.3% | -519.2% | 30% |
| Net Income | -$54 | -$50 | -$47 | $29 |
| % Margin | -707.8% | -580.2% | -510.9% | 34.9% |
| EPS Diluted | -0.32 | -0.31 | -0.29 | 0.17 |
| % Growth | -3.2% | -6.9% | -270.6% | – |
| Operating Cash Flow | -$45 | -$46 | -$63 | -$44 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$45 | -$46 | -$63 | -$44 |